Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Drugs for Malaria Market 2018, Forecast to 2023
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
Scope of the Report:
This report focuses on the Drugs for Malaria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
The worldwide market for Drugs for Malaria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Drugs for Malaria Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drugs for Malaria, with sales, revenue, and price of Drugs for Malaria, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Malaria, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drugs for Malaria market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drugs for Malaria sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
Scope of the Report:
This report focuses on the Drugs for Malaria in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
The worldwide market for Drugs for Malaria is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- Prevention
- Treatment
- Other
Chapter 1, to describe Drugs for Malaria Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drugs for Malaria, with sales, revenue, and price of Drugs for Malaria, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Malaria, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drugs for Malaria market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drugs for Malaria sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Drugs for Malaria Introduction
1.2 Market Analysis by Type
1.2.1 Aryl Aminoalcohol Compounds
1.2.2 Antifolate Compounds
1.2.3 Artemisinin Compounds
1.3 Market Analysis by Applications
1.3.1 Prevention
1.3.2 Treatment
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Cipla
2.1.1 Business Overview
2.1.1.1 Cipla Description
2.1.1.2 Cipla Headquarter, Main Business and Finance Overview
2.1.2 Cipla Drugs for Malaria Product Introduction
2.1.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.1.2.2 Drugs for Malaria Product Information
2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Cipla Drugs for Malaria Market Share in 2017
2.2 Guilin Pharmaceutical
2.2.1 Business Overview
2.2.1.1 Guilin Pharmaceutical Description
2.2.1.2 Guilin Pharmaceutical Headquarter, Main Business and Finance Overview
2.2.2 Guilin Pharmaceutical Drugs for Malaria Product Introduction
2.2.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.2.2.2 Drugs for Malaria Product Information
2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Guilin Pharmaceutical Drugs for Malaria Market Share in 2017
2.3 IPCA Laboratories
2.3.1 Business Overview
2.3.1.1 IPCA Laboratories Description
2.3.1.2 IPCA Laboratories Headquarter, Main Business and Finance Overview
2.3.2 IPCA Laboratories Drugs for Malaria Product Introduction
2.3.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.3.2.2 Drugs for Malaria Product Information
2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global IPCA Laboratories Drugs for Malaria Market Share in 2017
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.1.1 GlaxoSmithKline Description
2.4.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.4.2 GlaxoSmithKline Drugs for Malaria Product Introduction
2.4.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.4.2.2 Drugs for Malaria Product Information
2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global GlaxoSmithKline Drugs for Malaria Market Share in 2017
2.5 Mylan Labs
2.5.1 Business Overview
2.5.1.1 Mylan Labs Description
2.5.1.2 Mylan Labs Headquarter, Main Business and Finance Overview
2.5.2 Mylan Labs Drugs for Malaria Product Introduction
2.5.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.5.2.2 Drugs for Malaria Product Information
2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Mylan Labs Drugs for Malaria Market Share in 2017
2.6 Roche
2.6.1 Business Overview
2.6.1.1 Roche Description
2.6.1.2 Roche Headquarter, Main Business and Finance Overview
2.6.2 Roche Drugs for Malaria Product Introduction
2.6.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.6.2.2 Drugs for Malaria Product Information
2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Roche Drugs for Malaria Market Share in 2017
2.7 Novartis
2.7.1 Business Overview
2.7.1.1 Novartis Description
2.7.1.2 Novartis Headquarter, Main Business and Finance Overview
2.7.2 Novartis Drugs for Malaria Product Introduction
2.7.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.7.2.2 Drugs for Malaria Product Information
2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Novartis Drugs for Malaria Market Share in 2017
2.8 Sanofi Aventis
2.8.1 Business Overview
2.8.1.1 Sanofi Aventis Description
2.8.1.2 Sanofi Aventis Headquarter, Main Business and Finance Overview
2.8.2 Sanofi Aventis Drugs for Malaria Product Introduction
2.8.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.8.2.2 Drugs for Malaria Product Information
2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Sanofi Aventis Drugs for Malaria Market Share in 2017
2.9 Ajanta Pharma
2.9.1 Business Overview
2.9.1.1 Ajanta Pharma Description
2.9.1.2 Ajanta Pharma Headquarter, Main Business and Finance Overview
2.9.2 Ajanta Pharma Drugs for Malaria Product Introduction
2.9.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.9.2.2 Drugs for Malaria Product Information
2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Ajanta Pharma Drugs for Malaria Market Share in 2017
3 GLOBAL DRUGS FOR MALARIA MARKET COMPETITION, BY MANUFACTURER
3.1 Global Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Drugs for Malaria Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Malaria Manufacturer Market Share in 2017
3.4.2 Top 5 Drugs for Malaria Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL DRUGS FOR MALARIA MARKET ANALYSIS BY REGIONS
4.1 Global Drugs for Malaria Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Malaria Sales by Regions (2013-2018)
4.1.2 Global Drugs for Malaria Revenue by Regions (2013-2018)
4.2 North America Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Malaria Sales by Countries (2013-2018)
5.1.2 North America Drugs for Malaria Revenue by Countries (2013-2018)
5.1.3 United States Drugs for Malaria Sales and Growth Rate (2013-2018)
5.1.4 Canada Drugs for Malaria Sales and Growth Rate (2013-2018)
5.1.5 Mexico Drugs for Malaria Sales and Growth Rate (2013-2018)
5.2 North America Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Drugs for Malaria Sales by Manufacturers (2016-2017)
5.2.2 North America Drugs for Malaria Revenue by Manufacturers (2016-2017)
5.3 North America Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Drugs for Malaria Sales and Sales Share by Type (2013-2018)
5.3.2 North America Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
5.4 North America Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Drugs for Malaria Sales and Sales Share by Application (2013-2018)
5.4.2 North America Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
6 EUROPE DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Drugs for Malaria Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Malaria Sales by Countries (2013-2018)
6.1.2 Europe Drugs for Malaria Revenue by Countries (2013-2018)
6.1.3 Germany Drugs for Malaria Sales and Growth Rate (2013-2018)
6.1.4 UK Drugs for Malaria Sales and Growth Rate (2013-2018)
6.1.5 France Drugs for Malaria Sales and Growth Rate (2013-2018)
6.1.6 Russia Drugs for Malaria Sales and Growth Rate (2013-2018)
6.1.7 Italy Drugs for Malaria Sales and Growth Rate (2013-2018)
6.2 Europe Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Drugs for Malaria Sales by Manufacturers (2016-2017)
6.2.2 Europe Drugs for Malaria Revenue by Manufacturers (2016-2017)
6.3 Europe Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Drugs for Malaria Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Drugs for Malaria Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Malaria Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Drugs for Malaria Revenue by Countries (2013-2018)
7.1.3 China Drugs for Malaria Sales and Growth Rate (2013-2018)
7.1.4 Japan Drugs for Malaria Sales and Growth Rate (2013-2018)
7.1.5 Korea Drugs for Malaria Sales and Growth Rate (2013-2018)
7.1.6 India Drugs for Malaria Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Drugs for Malaria Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Drugs for Malaria Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Drugs for Malaria Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Drugs for Malaria Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Drugs for Malaria Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Drugs for Malaria Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Malaria Sales by Countries (2013-2018)
8.1.2 South America Drugs for Malaria Revenue by Countries (2013-2018)
8.1.3 Brazil Drugs for Malaria Sales and Growth Rate (2013-2018)
8.1.4 Argentina Drugs for Malaria Sales and Growth Rate (2013-2018)
8.1.5 Colombia Drugs for Malaria Sales and Growth Rate (2013-2018)
8.2 South America Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Drugs for Malaria Sales by Manufacturers (2016-2017)
8.2.2 South America Drugs for Malaria Revenue by Manufacturers (2016-2017)
8.3 South America Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Drugs for Malaria Sales and Sales Share by Type (2013-2018)
8.3.2 South America Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
8.4 South America Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Drugs for Malaria Sales and Sales Share by Application (2013-2018)
8.4.2 South America Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Malaria Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Drugs for Malaria Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Drugs for Malaria Sales and Growth Rate (2013-2018)
9.1.4 UAE Drugs for Malaria Sales and Growth Rate (2013-2018)
9.1.5 Egypt Drugs for Malaria Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Drugs for Malaria Sales and Growth Rate (2013-2018)
9.1.7 South Africa Drugs for Malaria Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Drugs for Malaria Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Drugs for Malaria Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Drugs for Malaria Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Drugs for Malaria Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL DRUGS FOR MALARIA MARKET SEGMENT BY TYPE
10.1 Global Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drugs for Malaria Sales and Market Share by Type (2013-2018)
10.1.2 Global Drugs for Malaria Revenue and Market Share by Type (2013-2018)
10.2 Aryl Aminoalcohol Compounds Sales Growth and Price
10.2.1 Global Aryl Aminoalcohol Compounds Sales Growth (2013-2018)
10.2.2 Global Aryl Aminoalcohol Compounds Price (2013-2018)
10.3 Antifolate Compounds Sales Growth and Price
10.3.1 Global Antifolate Compounds Sales Growth (2013-2018)
10.3.2 Global Antifolate Compounds Price (2013-2018)
10.4 Artemisinin Compounds Sales Growth and Price
10.4.1 Global Artemisinin Compounds Sales Growth (2013-2018)
10.4.2 Global Artemisinin Compounds Price (2013-2018)
11 GLOBAL DRUGS FOR MALARIA MARKET SEGMENT BY APPLICATION
11.1 Global Drugs for Malaria Sales Market Share by Application (2013-2018)
11.2 Prevention Sales Growth (2013-2018)
11.3 Treatment Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 DRUGS FOR MALARIA MARKET FORECAST (2018-2023)
12.1 Global Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)
12.2 Drugs for Malaria Market Forecast by Regions (2018-2023)
12.2.1 North America Drugs for Malaria Market Forecast (2018-2023)
12.2.2 Europe Drugs for Malaria Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drugs for Malaria Market Forecast (2018-2023)
12.2.4 South America Drugs for Malaria Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drugs for Malaria Market Forecast (2018-2023)
12.3 Drugs for Malaria Market Forecast by Type (2018-2023)
12.3.1 Global Drugs for Malaria Sales Forecast by Type (2018-2023)
12.3.2 Global Drugs for Malaria Market Share Forecast by Type (2018-2023)
12.4 Drugs for Malaria Market Forecast by Application (2018-2023)
12.4.1 Global Drugs for Malaria Sales Forecast by Application (2018-2023)
12.4.2 Global Drugs for Malaria Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Drugs for Malaria Introduction
1.2 Market Analysis by Type
1.2.1 Aryl Aminoalcohol Compounds
1.2.2 Antifolate Compounds
1.2.3 Artemisinin Compounds
1.3 Market Analysis by Applications
1.3.1 Prevention
1.3.2 Treatment
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Cipla
2.1.1 Business Overview
2.1.1.1 Cipla Description
2.1.1.2 Cipla Headquarter, Main Business and Finance Overview
2.1.2 Cipla Drugs for Malaria Product Introduction
2.1.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.1.2.2 Drugs for Malaria Product Information
2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Cipla Drugs for Malaria Market Share in 2017
2.2 Guilin Pharmaceutical
2.2.1 Business Overview
2.2.1.1 Guilin Pharmaceutical Description
2.2.1.2 Guilin Pharmaceutical Headquarter, Main Business and Finance Overview
2.2.2 Guilin Pharmaceutical Drugs for Malaria Product Introduction
2.2.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.2.2.2 Drugs for Malaria Product Information
2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Guilin Pharmaceutical Drugs for Malaria Market Share in 2017
2.3 IPCA Laboratories
2.3.1 Business Overview
2.3.1.1 IPCA Laboratories Description
2.3.1.2 IPCA Laboratories Headquarter, Main Business and Finance Overview
2.3.2 IPCA Laboratories Drugs for Malaria Product Introduction
2.3.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.3.2.2 Drugs for Malaria Product Information
2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global IPCA Laboratories Drugs for Malaria Market Share in 2017
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.1.1 GlaxoSmithKline Description
2.4.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
2.4.2 GlaxoSmithKline Drugs for Malaria Product Introduction
2.4.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.4.2.2 Drugs for Malaria Product Information
2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global GlaxoSmithKline Drugs for Malaria Market Share in 2017
2.5 Mylan Labs
2.5.1 Business Overview
2.5.1.1 Mylan Labs Description
2.5.1.2 Mylan Labs Headquarter, Main Business and Finance Overview
2.5.2 Mylan Labs Drugs for Malaria Product Introduction
2.5.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.5.2.2 Drugs for Malaria Product Information
2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Mylan Labs Drugs for Malaria Market Share in 2017
2.6 Roche
2.6.1 Business Overview
2.6.1.1 Roche Description
2.6.1.2 Roche Headquarter, Main Business and Finance Overview
2.6.2 Roche Drugs for Malaria Product Introduction
2.6.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.6.2.2 Drugs for Malaria Product Information
2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Roche Drugs for Malaria Market Share in 2017
2.7 Novartis
2.7.1 Business Overview
2.7.1.1 Novartis Description
2.7.1.2 Novartis Headquarter, Main Business and Finance Overview
2.7.2 Novartis Drugs for Malaria Product Introduction
2.7.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.7.2.2 Drugs for Malaria Product Information
2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Novartis Drugs for Malaria Market Share in 2017
2.8 Sanofi Aventis
2.8.1 Business Overview
2.8.1.1 Sanofi Aventis Description
2.8.1.2 Sanofi Aventis Headquarter, Main Business and Finance Overview
2.8.2 Sanofi Aventis Drugs for Malaria Product Introduction
2.8.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.8.2.2 Drugs for Malaria Product Information
2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Sanofi Aventis Drugs for Malaria Market Share in 2017
2.9 Ajanta Pharma
2.9.1 Business Overview
2.9.1.1 Ajanta Pharma Description
2.9.1.2 Ajanta Pharma Headquarter, Main Business and Finance Overview
2.9.2 Ajanta Pharma Drugs for Malaria Product Introduction
2.9.2.1 Drugs for Malaria Production Bases, Sales Regions and Major Competitors
2.9.2.2 Drugs for Malaria Product Information
2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Ajanta Pharma Drugs for Malaria Market Share in 2017
3 GLOBAL DRUGS FOR MALARIA MARKET COMPETITION, BY MANUFACTURER
3.1 Global Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Drugs for Malaria Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Malaria Manufacturer Market Share in 2017
3.4.2 Top 5 Drugs for Malaria Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL DRUGS FOR MALARIA MARKET ANALYSIS BY REGIONS
4.1 Global Drugs for Malaria Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Malaria Sales by Regions (2013-2018)
4.1.2 Global Drugs for Malaria Revenue by Regions (2013-2018)
4.2 North America Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Drugs for Malaria Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Malaria Sales by Countries (2013-2018)
5.1.2 North America Drugs for Malaria Revenue by Countries (2013-2018)
5.1.3 United States Drugs for Malaria Sales and Growth Rate (2013-2018)
5.1.4 Canada Drugs for Malaria Sales and Growth Rate (2013-2018)
5.1.5 Mexico Drugs for Malaria Sales and Growth Rate (2013-2018)
5.2 North America Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Drugs for Malaria Sales by Manufacturers (2016-2017)
5.2.2 North America Drugs for Malaria Revenue by Manufacturers (2016-2017)
5.3 North America Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Drugs for Malaria Sales and Sales Share by Type (2013-2018)
5.3.2 North America Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
5.4 North America Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Drugs for Malaria Sales and Sales Share by Application (2013-2018)
5.4.2 North America Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
6 EUROPE DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Drugs for Malaria Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Malaria Sales by Countries (2013-2018)
6.1.2 Europe Drugs for Malaria Revenue by Countries (2013-2018)
6.1.3 Germany Drugs for Malaria Sales and Growth Rate (2013-2018)
6.1.4 UK Drugs for Malaria Sales and Growth Rate (2013-2018)
6.1.5 France Drugs for Malaria Sales and Growth Rate (2013-2018)
6.1.6 Russia Drugs for Malaria Sales and Growth Rate (2013-2018)
6.1.7 Italy Drugs for Malaria Sales and Growth Rate (2013-2018)
6.2 Europe Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Drugs for Malaria Sales by Manufacturers (2016-2017)
6.2.2 Europe Drugs for Malaria Revenue by Manufacturers (2016-2017)
6.3 Europe Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Drugs for Malaria Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Drugs for Malaria Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Malaria Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Drugs for Malaria Revenue by Countries (2013-2018)
7.1.3 China Drugs for Malaria Sales and Growth Rate (2013-2018)
7.1.4 Japan Drugs for Malaria Sales and Growth Rate (2013-2018)
7.1.5 Korea Drugs for Malaria Sales and Growth Rate (2013-2018)
7.1.6 India Drugs for Malaria Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Drugs for Malaria Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Drugs for Malaria Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Drugs for Malaria Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Drugs for Malaria Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Drugs for Malaria Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Drugs for Malaria Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Malaria Sales by Countries (2013-2018)
8.1.2 South America Drugs for Malaria Revenue by Countries (2013-2018)
8.1.3 Brazil Drugs for Malaria Sales and Growth Rate (2013-2018)
8.1.4 Argentina Drugs for Malaria Sales and Growth Rate (2013-2018)
8.1.5 Colombia Drugs for Malaria Sales and Growth Rate (2013-2018)
8.2 South America Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Drugs for Malaria Sales by Manufacturers (2016-2017)
8.2.2 South America Drugs for Malaria Revenue by Manufacturers (2016-2017)
8.3 South America Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Drugs for Malaria Sales and Sales Share by Type (2013-2018)
8.3.2 South America Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
8.4 South America Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Drugs for Malaria Sales and Sales Share by Application (2013-2018)
8.4.2 South America Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA DRUGS FOR MALARIA BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Malaria Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Drugs for Malaria Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Drugs for Malaria Sales and Growth Rate (2013-2018)
9.1.4 UAE Drugs for Malaria Sales and Growth Rate (2013-2018)
9.1.5 Egypt Drugs for Malaria Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Drugs for Malaria Sales and Growth Rate (2013-2018)
9.1.7 South Africa Drugs for Malaria Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Drugs for Malaria Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Drugs for Malaria Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Drugs for Malaria Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Drugs for Malaria Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Drugs for Malaria Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Drugs for Malaria Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Drugs for Malaria Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL DRUGS FOR MALARIA MARKET SEGMENT BY TYPE
10.1 Global Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drugs for Malaria Sales and Market Share by Type (2013-2018)
10.1.2 Global Drugs for Malaria Revenue and Market Share by Type (2013-2018)
10.2 Aryl Aminoalcohol Compounds Sales Growth and Price
10.2.1 Global Aryl Aminoalcohol Compounds Sales Growth (2013-2018)
10.2.2 Global Aryl Aminoalcohol Compounds Price (2013-2018)
10.3 Antifolate Compounds Sales Growth and Price
10.3.1 Global Antifolate Compounds Sales Growth (2013-2018)
10.3.2 Global Antifolate Compounds Price (2013-2018)
10.4 Artemisinin Compounds Sales Growth and Price
10.4.1 Global Artemisinin Compounds Sales Growth (2013-2018)
10.4.2 Global Artemisinin Compounds Price (2013-2018)
11 GLOBAL DRUGS FOR MALARIA MARKET SEGMENT BY APPLICATION
11.1 Global Drugs for Malaria Sales Market Share by Application (2013-2018)
11.2 Prevention Sales Growth (2013-2018)
11.3 Treatment Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 DRUGS FOR MALARIA MARKET FORECAST (2018-2023)
12.1 Global Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)
12.2 Drugs for Malaria Market Forecast by Regions (2018-2023)
12.2.1 North America Drugs for Malaria Market Forecast (2018-2023)
12.2.2 Europe Drugs for Malaria Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drugs for Malaria Market Forecast (2018-2023)
12.2.4 South America Drugs for Malaria Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drugs for Malaria Market Forecast (2018-2023)
12.3 Drugs for Malaria Market Forecast by Type (2018-2023)
12.3.1 Global Drugs for Malaria Sales Forecast by Type (2018-2023)
12.3.2 Global Drugs for Malaria Market Share Forecast by Type (2018-2023)
12.4 Drugs for Malaria Market Forecast by Application (2018-2023)
12.4.1 Global Drugs for Malaria Sales Forecast by Application (2018-2023)
12.4.2 Global Drugs for Malaria Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Drugs for Malaria Picture
Table Product Specifications of Drugs for Malaria
Figure Global Drugs for Malaria CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Globa
Figure Drugs for Malaria Picture
Table Product Specifications of Drugs for Malaria
Figure Global Drugs for Malaria CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Globa
